Pregnancy and Postpartum CGM in Gestational Diabetes
This observational study is looking at how continuous glucose monitor (CGM) data from the Dexcom G7 can help predict blood sugar levels after pregnancy in women who had gestational diabetes (diabetes during pregnancy). We want to see if CGM readings during your third trimester and up to 14 days after giving birth can tell us if you might have abnormal blood sugars later on. The main goal is to see how well CGM data can identify women who have a specific blood sugar result (TIR <96%) up to 12 weeks after delivery. We are looking for about 40 women who are 18 or older, have gestational diabetes in their current pregnancy, and are already prescribed a Dexcom G7. This study is currently recruiting participants.
- Study design
- This is an observational study involving about 40 women. It is not a randomized trial.
- What's involved
- You will use your Dexcom G7 as usual during pregnancy and wear one sensor after delivery. You will also have a standard blood sugar test (OGTT) around 6 weeks postpartum and complete a remote questionnaire after that test.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants are followed up to 12 weeks postpartum for the primary endpoint.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Pregnancy and Postpartum CGM in GDM
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Grenye O'Malley, MD · PRINCIPAL_INVESTIGATOR · Icahn School of Medicine at Mount Sinai
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Sensitivity of postpartum TIR <96%up to 12 weeks postpartum
Sensitivity of postpartum time in range (TIR) \<96% to predict dysglycemia on OGTT. Range 70-180 mg/dL. Sensitivity determined by true positives of TIR \<96% and abnormal OGTT and false negatives would be TIR \<96% with normal OGTT.